Lv3
390 积分 2022-03-28 加入
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
17小时前
已完结
Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
17小时前
已完结
Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA-HD Study Extension
17小时前
已完结
Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial
17小时前
已完结
Quantitative prediction of bone mineral density by using bone turnover markers in response to antiresorptive agents in postmenopausal osteoporosis: A model‐based meta‐analysis
18小时前
已完结
Monitoring individual response to hormone replacement therapy with bone markers
18小时前
已完结
Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women
18小时前
已完结
Relationship Between Changes in Biochemical Markers of Bone Turnover and BMD to Predict Vertebral Fracture Risk
19小时前
已完结
Bad bones: how a landmark US FDA decision could help patients with osteoporosis
21小时前
已完结
Nutrition and Osteoporosis Prevention
23小时前
已完结
皖公网安备34019202002308
